Overview

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved cholesterol lowering medication.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe
Criteria
Inclusion Criteria:

- Patients with elevated cholesterol and coronary heart disease

Exclusion Criteria:

- Patients who have cholesterol levels within normal ranges as identified by the study